BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7017189)

  • 1. [Double-blind comparison of L-keflex and cephalexin (Keflex) in dental infections (author's transl)].
    Horii M; Morinaga T; Shimada S; Takeuchi T; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Ikeda S; Takada S; Iizuka O; Kimura J; Sagara S; Inada Y; Nishioka Y; Kimata M
    Jpn J Antibiot; 1980 Nov; 33(11):1194-214. PubMed ID: 7017189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fundamental and clinical studies of sustained release cephalexin (L-Keflex) in the field of oral surgery (author's transl)].
    Morihana T; Ueda K; Muraoka M; Tsushima T; Kodama M; Nagata K; Nakao K; Shimada K
    Jpn J Antibiot; 1980 Apr; 33(4):514-21. PubMed ID: 6997536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A double-blind comparison between cefaclor and cephalexin in the treatment of dental infections].
    Horii M; Morinaga T; Takeuchi T; Shimada S; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Takada S
    Jpn J Antibiot; 1984 Jan; 37(1):152-75. PubMed ID: 6374193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of sustained release preparations of cefaclor in dental infections. Comparative double blind clinical studies of sustained release preparations with a regular preparation of cefaclor].
    Horii M; Shimada S; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Inaba O; Takada S; Kimura J
    Jpn J Antibiot; 1985 Apr; 38(4):1117-40. PubMed ID: 3897614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study of sustained release cephalexin (S-6436, S-6437) in dermatology (author's transl)].
    Okita K; Sato M; Hayakawa K; Kimura K
    Jpn J Antibiot; 1977 Nov; 30(11):911-5. PubMed ID: 592493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experience with sustained release cefalexin (S-6437) for pediatric use in pediatrics (author's transl)].
    Hayashi M; Sugita K; Murata R; Fujii K
    Jpn J Antibiot; 1977 Nov; 30(11):881-7. PubMed ID: 592488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience with sustained release cephalexin (X-6437) (author's transl)].
    Kato R; Asano Y; Tsuzuki K; Iwayama S; Ito S
    Jpn J Antibiot; 1977 Nov; 30(11):888-92. PubMed ID: 592489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experience with sustained release cephalexin (S-6437) in pediatrics (author's transl)].
    Hori M; Okamoto K; Kohno S
    Jpn J Antibiot; 1978 Feb; 31(2):59-71. PubMed ID: 642208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experience with sustained release cefalexin (author's transl)].
    Takada K
    Jpn J Antibiot; 1977 Oct; 30(10):793-801. PubMed ID: 592481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Double-blind comparison of cefadroxil and cephalexin granules in the treatment of impetigo].
    Arata J; Nohara N; Suwaki M; Umemura S; Nakagawa S; Miyoshi K; Yamamoto Y; Nishihara O; Yamada M; Hiramatsu H
    Jpn J Antibiot; 1983 Jun; 36(6):1443-60. PubMed ID: 6361311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical study of sustained release cephalexin (S-6435 and S-6436) in tonsillitis and pharyngitis (author's transl)].
    Kubo N
    Jpn J Antibiot; 1977 Nov; 30(11):906-10. PubMed ID: 592492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies of sustained release cephalexin (S-6437) in pediatrics (author's transl)].
    Saito K; Ubukata K; Konno M
    Jpn J Antibiot; 1977 Sep; 30(9):672-6. PubMed ID: 916187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative studies of the efficacy, safety and usefulness of S6472, cefaclor and cephalexin on complicated urinary tract infection by the double-blind method].
    Kamidono S; Arakawa S; Fujii A; Kataoka N; Umezu K; Ishigami J; Hirooka K; Shimatani N; Matsushita M; Hikosaka K
    Jpn J Antibiot; 1985 Oct; 38(10):2735-69. PubMed ID: 3908727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical evaluation of S6472 (prolonged action preparation of cefaclor) in the treatment of skin and soft tissue infections. A double blind comparison of S6472 and cefaclor].
    Sakai K; Fujimoto M; Ueda T; Yura J; Shinagawa N; Ishikawa S; Tachi Y; Kobe A; Shibata Y; Doi S
    Jpn J Antibiot; 1985 Oct; 38(10):2716-34. PubMed ID: 3908726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sustained release cephalexin (S-6436) and genitourinary tract infection (author's transl)].
    Furusawa T; Tanaka S
    Jpn J Antibiot; 1977 Oct; 30(10):806-18. PubMed ID: 592483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of cephalexin hydrochloride and cephalexin monohydrate in the treatment of skin and soft tissue infections.
    Kumar A; Murray DL; Hanna CB; Kreindler TG; Jacobson KD; Bundy JM; Waxman K; Finnerty EF; Folan DW; Drucker WR
    Antimicrob Agents Chemother; 1988 Jun; 32(6):882-5. PubMed ID: 3046484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical experience with sustained release cefalexin (S-6436) in surgery (author's transl)].
    Takenaka M; Tanimura H; Kamata T; Setoyama M
    Jpn J Antibiot; 1977 Nov; 30(11):893-7. PubMed ID: 592490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical experience with sustained release cephalexin (S-6436) in urology (author's transl)].
    Konya H; Kuroda J; Iwao N
    Jpn J Antibiot; 1977 Nov; 30(11):898-905. PubMed ID: 592491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical examination of cephalexin (Keflex, L-Keflex) in pedodontics].
    Horii M; Sakinaka T; Matsui K; Murata A; Yoshihara M
    Shikai Tenbo; 1981 Mar; 57(3):577-86. PubMed ID: 6943711
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical studies of S-6437 in pediatrics (author's transl)].
    Nishimura T; Kotani Y; Hiromatsu K; Takashima T; Asatani Y
    Jpn J Antibiot; 1977 Sep; 30(9):722-8. PubMed ID: 916193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.